ArticlePloS one2024

Real-world visual acuity outcomes for patients with naïve neovascular age-related macular degeneration treated with aflibercept, ranibizumab, or bevacizumab in the Republic of Korea.

Yeo Jin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.